RLAY
Relay Therapeutics
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Relay Therapeutics presented clinical data supporting further development of Zovegalisib plus Atirmociclib triplet therapy in frontline metastatic breast cancerApr 27, 2026
- Relay Therapeutics' zovegalisib received FDA Breakthrough Therapy Designation for breast cancerFeb 4, 2026
- Relay Therapeutics reveals updated data for RLY-2608 + Fulvestrant showing meaningful progression-free survival at ASCO 2025Jun 2, 2025